HUBUNGAN ANTARA HbA1c DAN KADAR LIPID SERUM DENGAN DERAJAT BERAT RETINOPATI DIABETIKA

Authors

  • Safaruddin Refa Bagian / SMF Mata Fakultas Kedokteran Universitas Brawijaya / RSU dr. Saiful Anwar Malang
  • Nadia Artha Dewi Bagian / SMF Mata Fakultas Kedokteran Universitas Brawijaya / RSU dr. Saiful Anwar Malang

DOI:

https://doi.org/10.21776/ub.jkb.2005.021.03.6

Abstract

Diabetic retinopathy is a leading cause of blindness in industrial world and is rapidly becoming an important cause in developing countries. Many factors related with theseverity of diabetic retinopathy, such as HbA1c and serum lipid. The study wants to know whether those factors have any  correlation with the severity of diabetic retinopathy or not. The objective this study was to determine the correlation between HbA1c and serum lipid with the severity  of diabetic retinopathy. An analytic cross sectional observational research had been done at Saiful Anwar hospital. The samples (diabetic retinopaty patients) were taken with consecutive sampling. These patient underwent funduscopy, fundus photography, laboratory examination including HbA1c, serum lipid (total serum cholesterol, LDL, HDL, triglycerides), and blood glucose. These patient were questioned about risk factors previously determined by the authors. The laboratory findings were thease are compared to the severity of diabetic retinopathy.

Downloads

Download data is not yet available.

References

DAFTAR KEPUSTAKAAN

Sheetz MJ, King GL. Molecular understanding of Hyperglycemia’s Adverse Effect for Diabetic Complications. JAMA 2002; 288: 2579-2586.

Suhendro Gatut. Pembentukan Sikatrik Retina Perifer pada Nonproliferatif Retinopati Diabetik untuk Mempertahankan

Sistem Autoregulasi Retina Sentral. [Dissertation].Surabaya; Universitas Airlangga; 1999.

American Academy of Opthalmology staff. In: International Opthalmology. Basic and Clinical Science Course. Section 12. San Francisco: American Academy of Opthalmology; 2003-2004; 185-187.

Valero, Sherma. Retinopathy Diabetic,Background.eMedicine 2001; 1-10

Delengocky, Tayson. Diabetic Retinopathy. Texas: TOMA By Laws Amandement meeting; 2003 Feb 7th; 12-14.

DaSilva ZM, Freitas AM, Marcon, IM. Risk Factors Related To Severity of Diabetic Retinopathy. Arq Bras Opthalmol 2003; 66: 739-743.

American Academy of Opthalmology staff. In: Retina and vitreus. Basic and Clinical Science Course. Section 12.San

Francisco: American Academy of Opthalmology; 2003-2004; 70-86.

Kanski JJ. Retinal Vascular Disease. In: Kanski JJ,editor. Clinical Opthalmology. V th ed. London: Butterworth Heinemann; 2003; 439-455.

Viswanath K, Muray DD. Diabetic Retinopathy: Clinical Findings and Management. Journal of Community Eye Health 2003; 16: 21-24.

Tapp RJ, Shaw JE, Harper CA, DeCourten MP, Balkau B,McCarthy DJ, Taylor HR; et al. The Prevalence of and

Factors Associated with Diabetic Retinopathy in Australian Population. Diabetes Care 2003;26:1731-1737.

Benson WE, Tasman W, Duane TD. Diabetes Mellitus and the Eye. In: Tasman W, Jaeger EA, eds. Duane’s Clinical Opthalmology: Disease of The Retina.Philadelphia: JB Lippincott Company; 1994; 1-25.

Gillow JT, Gibson JM, Dodson PM. Hypertension and diabetic retinopathy: What’s the Story.Br J Opthalmol 1999;83:1083-1087.

VanLeiden HA, Dekker JM, Moli AC, Nijpels G, Heine RJ, Bouter LM; et al. Blood Pressure, Lipids, and Obesity are

Associated with Retinopathy.Diabetes Care 2002; 25: 1320-1325.

Valero SO. Retinopathy, Diabetic,Proliferative.eMedicine 2001; 1-7.

Hammes HP, Lin J, Ranner O, Shani M, Lundqvist A, Betsholtz C; et al. Pericytes and the Pathogenesis of diabetic Retinopathy.Diabetes 2002; 51: 3107-3112.

Radha V, Rema M, Mohan V. Genes and Diabetic Retinopathy. Indian J Opthalmol 2002; 50: 5-11.

Kinshuck David. What is the ‘HbA1c?’(serial online) 2004 April; 1(1): (5 screen). Available from: http://www.cdc.gov/cnnp.

Nathan DM. Relationship between Metabolic Control and Long Term Complications of Diabetes. In: Kahn CR, Weis GC, editors. Joslin’s Diabetes Mellitus. 13th ed. Philadelphia: Lea & Febiger; 1994: 36: 620-628.

West SK, Klein R, Rodriguez J, Munoz B, Broman AT, Sanchez R. Diabetes and Diabetic Retinopathy in a Mexican-American Population.Diabetes Care 2001; 24:1204-1209

Rohlfing CL, Wiedmeyer HM, Little RR, England JD, Tennill A, Goldstein DE. Defining The Relationship Between

Plasma Glucose and HbA1c. Diabetes Care 2002; 25: 275-278.

Davidson JA. Rationale for More aggressive Guidelines for Diabetic Control. Endocrine practice 2002; 8: 37-39.

Levetan CS. Hemoglobin A1c: Need to Standarize Them.Endocrine practice 2002; 8: 25-26.

Chew EY, Ferris FL. Non Proliferative Diabetic Retinopathy. In: Stephen J Ryan, editor. Retina. 3rd ed. St Louis: Mosby:2001; 1295-1305.

Cioffi GA, Graustam E, ALM A. Ocular circulation. In: Kauffman PL, ALM Albert, editors. Adler’s Physiology of The Eye. 10th editor.St Louis: Mosby; 2003; 775.

Waspadji S. Cellular immune Respon among Diabetic and Factors Affecting the Development of Diabetic Retinopathy.

In: Understanding of Ocular Diabetics.2nd Continuing Opthalmology Education. Jakarta, Indonesia; 1999 November 27-28;16-24

El Haddad OAW, Saad MK. Prevalence and Risk Factors for Diabetic Retinopathyamong Omani Diabetics. Br J Opthalmol 1998; 82: 901-906.

Jusman SW. Basic Concepts of Biochemistry in Diabetes Mellitus.In : Understanding of Ocular Diabetics.2nd Continuing Opthalmology Education.Jakarta, Indonesia; 1999 November 27-28; 2-14

Leung GM, Lam KSL. Diabetic Complication and Their Implications of Health Care in Asia. Hong Kong Medical Journal 2000; 6: 61-68.

King GL, Banskota NK. Mechanisms of Diabetic Microvascular Complications. In: Kahn CR, Weis GC, eds. Joslin’s Diabetes Mellitus. 13th ed.Philadelphia: Lea & Febiger; 1994; 37: 631-641.

Ciulla TA, Amador AG, Zinman B. Diabetic retinopathy and Macular Edema.Diabetes Care 2003; 26: 2653-2664.

Frank RN. Mechanisms in Diabetic Retinopathy. In:Stephen J Ryan, editor. Retina. 3rd ed. St Louis: Mosby; 2001;1259-1287.

Donelly R, Smith AM, Gardner ID, Morris AD.Vascular Complication of Diabetes. BMJ 2000; 320: 1062-1066.

Standl Ebenhard. International Diabetes Federation European Policy Group Standards for Diabetes. Endocrine Practice 2002; 8: 37-38.

Su DHW, Yeo KT. Diabetic Retinopathy and serum Lipids. Singapore Med J 2000; 41: 295-297.

Tailor Anitaben, Granger DN. Hypercholesterolemia Promotes P-Selectin-Dependent Platelet-Endothelial Cell Adhesion in Postcapillary Venules.Arterioscle Thromb Vasc Biol 2003; 23:675-680

Glass CK, Witztum JL. Atherosclerosis: The Road Ahead. 2004.

Lysons TJ, Jenkins AJ, Zheng D. Diabetic Retinopathy and Serum Lippoprotein subclasses in the DCCT/ EDIC cohort.

Invest opthalmol. Vis Sci 2004; 45: 910-918.

Howard BV, Howard WJ. The Pathophysiology and Treatment of Lipid Disorders in Diabetes Mellitus. In: Kahn CR, Weis GC, editors. Joslin’s Diabetes Mellitus. 13th ed. Philadelphia: Lea & Febiger;1994;21:372-381

Downloads

Published

2013-04-16

Issue

Vol. 21 No. 3 (2005)

Section

Research Article

License

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).